Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	5,765	3,721	2,025	1,245	1,128	2,581
Market Cap Growth	94.74%	83.80%	62.59%	10.35%	-56.28%	61.40%
Enterprise Value	5,539	3,508	1,812	1,061	1,121	2,589
Last Close Price	291.77	189.07	107.15	71.42	66.80	99.67
PE Ratio	31.74	29.90	-	23.88	-	45.18
Forward PE	42.33	35.20	53.58	35.07	298.37	298.37
PS Ratio	20.02	13.88	12.11	9.48	5.75	10.69
PB Ratio	6.01	3.66	2.44	1.78	1.89	3.14
P/TBV Ratio	8.86	5.39	4.42	4.18	8.11	7.85
P/FCF Ratio	44.25	76.09	21.26	27.04	8.99	36.86
P/OCF Ratio	44.16	75.39	20.86	25.12	8.19	32.76
PEG Ratio	1.74	2.42	3.57	2.34	23.42	18.19
EV/Sales Ratio	19.24	13.08	10.84	8.08	5.71	10.72
EV/EBITDA Ratio	42.03	43.32	31.11	22.90	27.11	22.09
EV/EBIT Ratio	55.85	74.32	78.73	108.04	369.11	39.07
EV/FCF Ratio	42.53	71.72	19.03	23.04	8.93	36.96
Debt / Equity Ratio	1.17	0.44	0.01	0.01	0.15	0.40
Debt / EBITDA Ratio	8.46	5.52	0.12	0.13	2.09	2.74
Debt / FCF Ratio	8.61	9.23	0.08	0.13	0.70	4.63
Net Debt / Equity Ratio	-0.23	-0.28	-0.30	-0.23	-0.21	-0.02
Net Debt / EBITDA Ratio	-1.70	-3.48	-4.27	-3.54	-3.00	-0.14
Net Debt / FCF Ratio	-1.72	-5.77	-2.61	-3.56	-0.99	-0.24
Asset Turnover	0.19	0.21	0.19	0.17	0.19	0.18
Inventory Turnover	4.24	8.24	1.71	1.88	4.38	3.50
Quick Ratio	30.83	21.83	8.32	12.49	2.50	10.39
Current Ratio	31.18	22.23	8.93	14.15	2.67	11.15
Return on Equity (ROE)	21.96%	13.47%	-0.53%	8.29%	-0.74%	9.98%
Return on Assets (ROA)	3.99%	2.36%	1.66%	0.79%	0.18%	3.11%
Return on Invested Capital (ROIC)	11.76%	5.61%	-6.59%	1.64%	-0.07%	8.50%
Return on Capital Employed (ROCE)	4.70%	3.10%	2.50%	1.30%	0.50%	5.30%
Earnings Yield	3.39%	3.34%	-0.20%	4.19%	-2.96%	2.21%
FCF Yield	2.26%	1.31%	4.70%	3.70%	11.12%	2.71%
Buyback Yield / Dilution	-12.96%	-10.96%	-3.00%	-5.27%	2.19%	-2.50%

SEC Filings: 10-K · 10-Q